官方服务：
资源简介：
Table quantifying the % and intensity of PD-L1 and CD47 in a subset of patients with adenocarcinoma and squamous cell carcinoma
应用场景：
创建时间：
2019-07-09
相关数据集
Additional file 1 of Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survival
Table S1. (summary of patient samples used for analysis), Table S2. (summary of patient clinical and DNA variant data), Table S3. (per-patient summary of driver variants and neoepitopes), Table S4. (m
Figshare2020-03-31 更新50
MOESM2 of The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort
Additional file 2: Table S2. Statistical correlation of gene signatures with response and survival in the whole cohort and in the NSCLC cohort.
Figshare2019-11-04 更新20
Table 3_Baseline neuronal antibodies in patients with small cell lung cancer are not necessarily associated with post-immune checkpoint inhibitors neurotoxicities.docx
Background and objectivesAutoantibodies against intracellular neuronal antigens (IC-Abs) can be found in neurologically asymptomatic patients with small cell lung cancer (SCLC) and have been proposed
NIAID Data Ecosystem00
Table1_Identification of the molecular characteristics associated with microsatellite status of colorectal cancer patients for the clinical application of immunotherapy.XLSX
Background: Mismatch repair-proficient (pMMR) microsatellite stability (MSS) in colorectal cancer (CRC) indicates an unfavorable therapeutic response to immunotherapy with immune checkpoint inhibitors
NIAID Data Ecosystem20
ML29755 RNA-seq data
Programmed death-ligand 1 (PD-L1) expression has been associated with response to PD-1/PD-L1 inhibition, but responses are also seen in patients with PD-L1 negative tumors when assessed immunohistoche
NIAID Data Ecosystem10
